Abstract
In a previous study, we found that rabbit anti-Toxoplasma gondii serum was capable of recognizing truncated T. gondii microneme protein 16 (TgMIC16), indicating that TgMIC16 is an essential antigenic T. gondii protein. However, the broad application of this recombinant protein is limited by its low expression level. In this study, we performed codon optimization of TgMIC16 by changing the codon-adaptation index from 0.22 to 1.0 without altering the amino acid sequence and expressed the optimized gene in three different Escherichia coli strains, followed by comparison of soluble recombinant-protein expression and yield. Our results showed that the recombinant protein rTgMIC16 was expressed as inclusion bodies in all three strains following optimization of induction parameters, and western blot analysis revealed the presence of a ~72-kD recombinant protein as a specific band following purification. A shuffle-expression strain was selected to amplify incubation products and induce expression, resulting in an overall rTgMIC16 yield of ~20 mg/L. These findings provide a basis for further investigation of TgMIC16 to elucidate its functions and interaction partners.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baneyx F, Mujacic M (2004) Recombinant protein folding and misfolding in Escherichia coli. Nat Biotechnol 22:1399–1408. doi:10.1038/nbt1029
Cérède O, Dubremetz JF, Soête M, Deslée D, Vial H, Bout D, Lebrun M (2005) Synergistic role of micronemal proteins in Toxoplasma gondii virulence. J Exp Med 201:453–463. doi:10.1084/jem.20041672
Choi JH, Lee SY (2004) Secretory and extracellular production of recombinant proteins using Escherichia coli. Appl Microbiol Biotechnol 64:625–635. doi:10.1007/s00253-004-1559-9
Dubey JP (2008) The history of Toxoplasma gondii—the first 100 years. J Eukaryot Microbiol 55:467–475. doi:10.1111/j.1550-7408.2008.00345.x
Flegr J (2013) How and why Toxoplasma makes us crazy. Trends Parasitol 29:156–163. doi:10.1016/j.pt.2013.01.007
Grigoroudis AI, McInnes C, Premnath PN, Kontopidis G (2015) Efficient soluble expression of active recombinant human cyclin A2 mediated by E. coli molecular chaperones. Protein Expr Purif 113:8–16. doi:10.1016/j.pep.2015.01.013 [Epub 2015 May 6]
Grote A, Hiller K, Scheer M, Münch R, Nörtemann B, Hempel DC, Jahn D (2005) JCat: a novel tool to adapt codon usage of a target gene to its potential expression host. Nucleic Acids Res. doi:10.1093/nar/gki376
Hinze-Selch D, Däubener W, Erdag S, Wilms S (2010) The diagnosis of a personality disorder increases the likelihood for seropositivity to Toxoplasma gondii in psychiatric patients. Folia Parasitol 57:129–135
Hoane JS, Carruthers VB, Striepen B, Morrison DP, Entzeroth R, Howe DK (2003) Analysis of the Sarcocystis neurona microneme protein SnMIC10: protein characteristics and expression during intracellular development. Int J Parasitol 33:671–679. doi:10.1016/S0020-7519(03)00031-6
Huynh MH, Rabenau KE, Harper JM, Beatty WL, Sibley LD, Carruthers VB (2003) Rapid invasion of host cells by Toxoplasma requires secretion of the MIC2–M2AP adhesive protein complex. EMBO J 22:2082–2090. doi:10.1093/emboj/cdg217
Itakura K, Hirose T, Crea R, Riggs A, Heyneker H, Bolivar F, Boyer H (1977) Expression in Escherichia coli of a chemically synthesized gene for the hormone somatostatin. Science 198:1056–1063. doi:10.1126/science.412251
Jongert E, Roberts CW, Gargano N, Förster-Wald E, Petersen E (2009) Vaccines against Toxoplasma gondii: challenges and opportunities. Mem Inst Oswaldo Cruz 104:252–266. doi:10.1590/S0074-02762009000200019
Kusbeci OY, Miman O, Yaman M, Aktepe OC, Yazar S (2011) Could Toxoplasma gondii have any role in Alzheimer disease? Alzheimer Dis Assoc Disord 25:1–3. doi:10.1097/WAD.0b013e3181f73bc2
Li J, Cui Y, Yin K, Liu G-Z, Xiao T, Xu C, Huang B-C, Wei Q-K, Sun H (2016) Prokaryotic expression, purification and immunological characterization of micronemal protein 16 of Toxoplasma gondii. Chin J Parasitol Parasit Dis 34(3):198–202 (in chinese)
Miman O, Kusbeci OY, Aktepe OC, Cetinkaya Z (2010) The probable relation between Toxoplasma gondii and Parkinson’s disease. Neurosci Lett 475:129–131. doi:10.1016/j.neulet.2010.03.057
Montoya JG, Liesenfeld O (2004) Toxoplasmosis. Lancet 363(9425):1965–1976. doi:10.1016/S0140-6736(04)16412-X
Narciandi RE, Mörbe FJ, Riesenberg D (1996) Maximizing the expression of recombinant Kringle 1 (Streptokinase) synthesized in Escherichia coli. Influence of culture and induction conditions. Biotechnol Lett 18(11):1261–1266. doi:10.1007/BF00129951
Reiss M, Viebig N, Brecht S, Fourmaux MN, Soete M, Di Cristina M, Dubremetz JF, Soldati D (2001) Identification and characterization of an escorter for two secretory adhesins in Toxoplasma gondii. J Cell Biol 153:563–578
Soldati D, Dubremetz JF, Lebrun M (2001) Microneme proteins: structural and functional requirements to promote adhesion and invasion by the apicomplexan parasite Toxoplasma gondii. Int J Parasitol 31:1293–1302. doi:10.1016/S0020-7519(01)00257-0
Sørensen HP, Mortensen KK (2005) Soluble expression of recombinant proteins in the cytoplasm of Escherichia coli. Microb Cell Fact 4:1. doi:10.1186/1475-2859-4-1
Tenter AM, Heckeroth AR, Weiss LM (2000) Toxoplasma gondii: from animals to humans. Int J Parasitol 30:1217–1258. doi:10.1016/S0020-7519(00)00124-7
Tomley FM, Soldati DS (2001) Mix and match modules: structure and function of microneme proteins in apicomplexan parasites. Trends Parasitol 17:81–88. doi:10.1016/S1471-4922(00)01761-X
Torrey EF, Yolken RH (2013) Toxoplasma oocysts as a public health problem. Trends Parasitol 29:380–384. doi:10.1016/j.pt.2013.06.001
Tuller T, Waldman YY, Kupiec M, Ruppin E (2010) Translation efficiency is determined by both codon bias and folding energy. Proc Natl Acad Sci USA 107:3645–3650. doi:10.1073/pnas.0909910107
Zhang N-Z, Chen J, Wang M, Petersen E, Zhu X-Q (2013) Vaccines against Toxoplasma gondii: new developments and perspectives. Expert Rev Vaccines 12:1287–1299. doi:10.1586/14760584.2013.844652
Zhang N-Z, Wang M, Xu Y, Petersen E, Zhu X-Q (2015) Recent advances in developing vaccines against Toxoplasma gondii: an update. Expert Rev Vaccines 14:1609–1621. doi:10.1586/14760584.2015.1098539
Acknowledgements
This work was supported by the grant from the National Natural Science Foundation of China to HS (No. 81501770), the grant from the Natural Science Foundation of Shandong Province to HS (No. ZR2015YL051), and the grant from The Innovation Project of Shandong Academy of Medical Sciences.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Rights and permissions
About this article
Cite this article
Sun, H., Li, J., Liu, Gz. et al. Expression of codon-optimized TgMIC16 in three Escherichia coli strains. 3 Biotech 7, 270 (2017). https://doi.org/10.1007/s13205-017-0885-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s13205-017-0885-4